相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice
Patricia Recio-Lopez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
Fanny Jansson Sigfrids et al.
JOURNAL OF INTERNAL MEDICINE (2022)
Distribution of seven ApoC-III glycoforms in plasma, VLDL, IDL, LDL and HDL of healthy subjects
Marina Rodriguez et al.
JOURNAL OF PROTEOMICS (2022)
Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)
Azusa Yamazaki et al.
BIOLOGICAL CHEMISTRY (2021)
Identification of biomarker panels as predictors of severity in coronary artery disease
Assia Ben Braiek et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Lowering apolipoprotein CIII protects against high-fat diet-induced metabolic derangements
Ismael Valladolid-Acebes et al.
SCIENCE ADVANCES (2021)
Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia
Yunpeng Guan et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups
Shiwali Goyal et al.
LIPIDS IN HEALTH AND DISEASE (2021)
ApoC-III is a novel inducer of calcification in human aortic valves
Florian Schlotter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer's disease
Yueming Hu et al.
JOURNAL OF LIPID RESEARCH (2021)
Apolipoprotein CIII and Angiopoietin-like Protein 8 are Elevated in Lipodystrophy and Decrease after Metreleptin
Marissa Lightbourne et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2021)
Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg et al.
EUROPEAN HEART JOURNAL (2021)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
Julius L. Katzmann et al.
LIPIDS IN HEALTH AND DISEASE (2020)
Remnant lipoproteins: are they equal to or more atherogenic than LDL?
Carlos A. Aguilar Salinas et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?
Laurens F. Reeskamp et al.
CURRENT OPINION IN LIPIDOLOGY (2020)
Network determinants of cardiovascular calcification and repositioned drug treatments
Euijun Song et al.
FASEB JOURNAL (2020)
The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans
Jan Boren et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease
Guenther Silbernagel et al.
ATHEROSCLEROSIS (2020)
Human postprandial responses to food and potential for precision nutrition
Sarah E. Berry et al.
NATURE MEDICINE (2020)
ApoCIII: A multifaceted protein in cardiometabolic disease
Laura D'Erasmo et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
Remnant lipoproteins and atherosclerotic cardiovascular disease
Hayato Tada et al.
CLINICA CHIMICA ACTA (2019)
Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2019)
Targeting RNA to lower triglycerides: long strides from short molecules
Arman Qamar et al.
EUROPEAN HEART JOURNAL (2019)
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
Veronica J. Alexander et al.
EUROPEAN HEART JOURNAL (2019)
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome
J. L. Witztum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Effects of APOC3 Heterozygous Deficiency on Plasma Lipid and Lipoprotein Metabolism
Gissette Reyes-Soffer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk: Mediation- and Meta-Analyses of 137895 Individuals
Anders B. Wulff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming
Anette Christ et al.
CELL (2018)
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen et al.
CIRCULATION (2018)
Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study
Julian C. van Capelleveen et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2018)
Increased inflammation, endoplasmic reticulum stress and oxidative stress in endothelial and macrophage cells exacerbate atherosclerosis in ApoCIII transgenic mice
Han Yingchun et al.
LIPIDS IN HEALTH AND DISEASE (2018)
Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk
Allyson M. Morton et al.
JCI INSIGHT (2018)
Postprandial Hyperlipidemia and Remnant Lipoproteins
Daisaku Masuda et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2017)
Changes in Low-density Lipoprotein size phenotypes associate with changes in apolipoprotein C-III glycoforms after dietary interventions
Saulo Mendoza et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2017)
A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels
Sumeet A. Khetarpal et al.
NATURE MEDICINE (2017)
Apolipoprotein CIII Overexpression-Induced Hypertriglyceridemia Increases Nonalcoholic Fatty Liver Disease in Association with Inflammation and Cell Death
Adriene A. Paiva et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease New Insights From Epidemiology, Genetics, and Biology
Borge G. Nordestgaard
CIRCULATION RESEARCH (2016)
Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
Marja-Riitta Taskinen et al.
CURRENT ATHEROSCLEROSIS REPORTS (2016)
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
Andres Digenio et al.
DIABETES CARE (2016)
Effect of Leptin Administration on Circulating Apolipoprotein CIII levels in Patients With Lipodystrophy
Andrea Kassai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Association between Apolipoprotein C-III Gene Polymorphisms and Coronary Heart Disease: A Meta-analysis
Jing-Zhan Zhang et al.
AGING AND DISEASE (2016)
Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 Diabetics
Arman Qamar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII
Haibo Li et al.
CARDIOVASCULAR RESEARCH (2015)
The pancreatic β-cell in deadly encounter with apolipoprotein CIII
Lisa Juntti-Berggren et al.
CELL CYCLE (2015)
The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
Frank M. Sacks
CURRENT OPINION IN LIPIDOLOGY (2015)
Association of APOC3 Loss-of-Function Mutations With Plasma Lipids and Subclinical Atherosclerosis The Multi-Ethnic BioImage Study
Pradeep Natarajan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates
Helena F. Raposo et al.
NUTRITION & METABOLISM (2015)
Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease
Alison B. Kohan
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2015)
Physiological regulation of lipoprotein lipase
Sander Kersten
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2014)
APOC3, Coronary Disease, and Complexities of Mendelian Randomization
Jonathan C. Cohen et al.
CELL METABOLISM (2014)
Rare Variant APOC3 R19X Is Associated With Cardio-Protective Profiles in a Diverse Population-Based Survey as Part of the Epidemiologic Architecture for Genes Linked to Environment Study
Dana C. Crawford et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Postprandial lipemia as a cardiometabolic risk factor
Angela Pirillo et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Apolipoprotein C-III is an Amyloid-beta-Binding Protein and an Early Marker for Alzheimer's Disease
Yao-Hsiang Shih et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
APOC3 mutations lower CVD risk
Tim Geach
Nature Reviews Cardiology (2014)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
Jacy Crosby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
Mark J. Graham et al.
CIRCULATION RESEARCH (2013)
Statins suppress apolipoprotein CIII-induced vascular endothelial cell activation and monocyte adhesion
Chunyu Zheng et al.
EUROPEAN HEART JOURNAL (2013)
Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
Sandrine Caron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Postprandial lipoprotein metabolism: VLDL vs chylomicrons
Katsuyuki Nakajima et al.
CLINICA CHIMICA ACTA (2011)
Lipodystrophies: Genetic and Acquired Body Fat Disorders
Abhimanyu Garg
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
Carlos O. Mendivil et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype
Chunyu Zheng et al.
CIRCULATION (2010)
Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis
Akio Kawakami et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Triglyceride-rich lipoprotein-associated apolipoprotein C-III production is stimulated by plasma free fatty acids in humans
Mirjana Pavlic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection
Toni I. Pollin et al.
SCIENCE (2008)
Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies
Giuseppe Danilo Norata et al.
ATHEROSCLEROSIS (2007)
Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells
Akio Kawakami et al.
CIRCULATION (2006)
Apolipoprotein CIII in apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells
A Kawakami et al.
CIRCULATION (2006)
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk
CQ Lai et al.
CURRENT OPINION IN LIPIDOLOGY (2005)
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
J Altomonte et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
On the structure and function of apolipoproteins: more than a family of lipid-binding proteins
VM Bolanos-Garcia et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2003)
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome
GF Watts et al.
DIABETES (2003)
分享论文
